文献速递鼻科

药物治疗对慢性鼻窦炎患者细菌微生物组的影响:一项初步研究

The effect of medical treatments on the bacterial microbiome in patients with chronic rhinosinusitis: a pilot study.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-03-08

结果显示细菌群落以棒状杆菌属和葡萄球菌属为主,治疗前后临床评分、细菌群落丰富度、多样性及细菌丰度均无显著差异,短期反应不可预测。

要点

  • 多西环素或泼尼松短期治疗对慢性鼻窦炎细菌群落的影响不可预测。
  • 治疗前后临床评分、群落丰富度、多样性和细菌丰度无显著差异。
  • 稳定期慢性鼻窦炎应合理使用全身性治疗以减少菌群失调风险。

核心结论

  • 细菌群落对抗生素或皮质类固醇治疗的短期反应不可预测。
  • 稳定期慢性鼻窦炎应合理使用全身性治疗以减少抗生素相关疾病负担和细菌菌群失调。

研究设计与样本

  • 治疗前后采集鼻拭子,使用16S rRNA基因靶向扩增子测序表征细菌群落,并通过定量PCR估计细菌丰度。
  • 记录22项鼻窦结局测试(SNOT-22)症状评分。

主要发现

  • 细菌谱以棒状杆菌属和葡萄球菌属成员为主。
  • 多西环素或泼尼松治疗患者的细菌群落变化各不相同且不可预测。
  • 多西环素治疗组中丙酸杆菌属平均相对丰度治疗后增加,泼尼松组中棒状杆菌属减少。
  • 治疗后临床评分、细菌群落丰富度、多样性及细菌丰度未见显著差异。

临床怎么用

  • 对于稳定期慢性鼻窦炎患者,应审慎使用全身性抗生素或皮质类固醇,以减少菌群失调和抗生素相关疾病负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotics and corticosteroids are prescribed to patients with chronic rhinosinusitis (CRS) to reduce bacterial burden and mucosal inflammation. Unfortunately, clinical improvement is often short-lived and symptoms frequently recur following cessation of treatment. The impact of these systemic therapies on bacterial communities is not well understood. Improved knowledge of how medical therapies influence the intranasal ecosystem may allow for more effective prescribing and the development of more targeted treatments. METHODS: Twenty patients with CRS were randomized to receive either doxycycline 100 mg twice daily or prednisone 30 mg once daily for 7 days. A further 6 patients with CRS were recruited as untreated controls. Swabs were taken immediately before and after the study period. Symptom scores (22-item Sino-Nasal Outcome Test [SNOT-22]) were recorded. Bacterial communities were characterized using 16S ribosomal RNA (rRNA) gene-targeted amplicon sequencing. Bacterial abundance was estimated using quantitative polymerase chain reaction (PCR) of 16S rRNA gene copies. RESULTS: Bacterial profiles were dominated by members of the genera Corynebacterium and Staphylococcus. Patients treated with either doxycycline or prednisone had variable and unpredictable changes in communities. The average relative abundance of Propionibacterium increased after treatment in the doxycycline treatment group, and Corynebacterium reduced in the prednisone group. Significant differences in clinical scores, bacterial community richness, diversity, and bacterial abundance were not seen after treatment. CONCLUSION: The short-term response of bacterial communities to antibiotic or corticosteroid therapy is unpredictable. This study suggests that the use of systemic therapy in patients with stable CRS should be rationalized to minimize antibiotic-associated morbidity and bacterial dysbiosis.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Jain R, Hoggard M, Zoing M, et al. The effect of medical treatments on the bacterial microbiome in patients with chronic rhinosinusitis: a pilot study. Int Forum Allergy Rhinol. 2018. PMID: 29517178. doi:10.1002/alr.22110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。